<?oxygen SCHSchema="clintrial-related-object-13.sch"?>
<!--Context: abstract[not(@abstract-type)]/sec[//related-object[@document-id-type='clinical-trial-number']]
Test: report    count(descendant::related-object[@document-id-type='clinical-trial-number']) gt 3
Message: There are  clinical trial numbers tagged in the structured abstract, which seems like a large number. Please check that this is correct and has not been mistagged. -->
<root xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/">
  <article>
    <abstract><sec id="abs1"><title>Background:</title><p>Hypoxia and consequent production of vascular endothelial growth factor A (VEGFA) promotes blood vessel leakiness and edema in ocular diseases. Anti-VEGFA therapeutics may aggravate hypoxia; therefore, therapy development is needed.</p></sec><sec id="abs2"><title>Methods:</title><p>Oxygen-induced retinopathy was used as a model to test the role of nitric oxide (NO) in pathological neovascularization and vessel permeability. Suppression of NO formation was achieved chemically using L-NMMA, or genetically, in endothelial NO synthase (eNOS) serine to alanine (S1176A) mutant mice.</p></sec><sec id="abs3"><title>Results:</title><p>Suppression of NO formation resulted in reduced retinal neoangiogenesis. Remaining vascular tufts exhibited reduced vascular leakage through stabilized endothelial adherens junctions, manifested as reduced phosphorylation of vascular endothelial (VE)-cadherin Y685 in a c-Src-dependent manner. Treatment with a single dose of L-NMMA in established retinopathy restored the vascular barrier and prevented leakage.</p></sec><sec id="abs4"><title>Conclusions:</title><p>We conclude that NO destabilizes adherens junctions, resulting in vascular hyperpermeability, by converging with the VEGFA/VEGFR2/c-Src/VE-cadherin pathway.</p></sec><sec id="abs5"><title>Funding:</title><p>This study was supported by the Swedish Cancer foundation (19 0119 Pj 01 hr), the Swedish Research Council (2020–01349), the Knut and Alice Wallenberg foundation (KAW 2020.0057) and a Fondation Leducq Transatlantic Network of Excellence Grant in Neurovascular Disease (17 CVD 03). KAW also supported LCW with a Wallenberg Scholar grant (2015.0275). WCS was supported by Grants R35 HL139945, P01 HL1070205, AHA MERIT Award.</p></sec><sec id="abs6"><title>Clinical trial number:</title><p><related-object id="RO1" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="eNOS;" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/eNOS;">eNOS;</related-object>, <related-object id="RO2" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="endothelial" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/endothelial">endothelial</related-object>, <related-object id="RO3" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="nitric" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/nitric">nitric</related-object>, <related-object id="RO4" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="oxide" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/oxide">oxide</related-object>, <related-object id="RO5" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="synthase" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/synthase">synthase</related-object>, <related-object id="RO6" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="L-NMMA;" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/L-NMMA;">L-NMMA;</related-object>, <related-object id="RO7" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="Nω-Methyl-L-arginine" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/Nω-Methyl-L-arginine">Nω-Methyl-L-arginine</related-object>, <related-object id="RO8" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="acetate" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/acetate">acetate</related-object>, <related-object id="RO9" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="Nos3;" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/Nos3;">Nos3;</related-object>, <related-object id="RO10" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="gene" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/gene">gene</related-object>, <related-object id="RO11" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="designation" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/designation">designation</related-object>, <related-object id="RO12" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="for" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/for">for</related-object>, <related-object id="RO13" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="murine" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/murine">murine</related-object>, <related-object id="RO14" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="endothelial" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/endothelial">endothelial</related-object>, <related-object id="RO15" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="nitric" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/nitric">nitric</related-object>, <related-object id="RO16" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="oxide" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/oxide">oxide</related-object>, <related-object id="RO17" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="synthase" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/synthase">synthase</related-object>, <related-object id="RO18" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="3" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/3">3</related-object>, <related-object id="RO19" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="OIR;" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/OIR;">OIR;</related-object>, <related-object id="RO20" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="oxygen-induced" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/oxygen-induced">oxygen-induced</related-object>, <related-object id="RO21" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="retinopathy" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/retinopathy">retinopathy</related-object>, <related-object id="RO22" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="PLA;" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/PLA;">PLA;</related-object>, <related-object id="RO23" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="proximity" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/proximity">proximity</related-object>, <related-object id="RO24" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="ligation" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/ligation">ligation</related-object>, <related-object id="RO25" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="assay" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/assay">assay</related-object>, <related-object id="RO26" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="VEGFA;" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/VEGFA;">VEGFA;</related-object>, <related-object id="RO27" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="vascular" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/vascular">vascular</related-object>, <related-object id="RO28" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="endothelial" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/endothelial">endothelial</related-object>, <related-object id="RO29" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="growth" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/growth">growth</related-object>, <related-object id="RO30" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="factor" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/factor">factor</related-object>, <related-object id="RO31" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="A;" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/A;">A;</related-object>, <related-object id="RO32" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="VE-cadherin;" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/VE-cadherin;">VE-cadherin;</related-object>, <related-object id="RO33" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="vascular" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/vascular">vascular</related-object><related-object id="RO34" source-type="clinical-trials-registry" source-id="ClinicalTrials.gov" source-id-type="registry-name" document-id="endothelial-cadherin" document-id-type="clinical-trial-number" xlink:href="https://clinicaltrials.gov/show/endothelial-cadherin">endothelial-cadherin</related-object></p></sec></abstract>
  </article>
</root>